ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein.
In-Hyoung YangJi-Youn JungSung-Hyun KimEun-Seon YooNam-Pyo ChoHakmo LeeJeong-Yeon LeeSeong Doo HongJi-Ae ShinSung-Dae ChoPublished in: Cellular oncology (Dordrecht) (2019)
These results provide evidence that ABT-263 may serve as an effective therapeutic agent for the treatment of human oral cancer.